Alert Indications, Safety, and Warnings

IN.PACT Admiral drug-coated balloon for femoropopliteal disease

The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven primary endovascular therapy that treats femoropopliteal disease. It is indicated for de novo, restenotic, or in-stent restenotic lesions up to 360 mm, with reference vessel diameters of 4 to 7 mm.

Download brochure
IN.PACT Admiral drug-coated balloon on white background
Alert Indications, Safety, and Warnings

Overview

Tested. Trusted.

The IN.PACT Admiral DCB remains the market-leading DCB, backed by five years of efficacy data,1 even in complex lesions.2

See the data

Product details

Maintain long-term vessel patency with the IN.PACT Admiral drug-coated balloon (DCB), which provides durable, consistent, and safe outcomes across multiple clinical trials, as well as across complex patient and lesion types. With more than 3,500 patients enrolled in 21 clinical studies and 500,000+ patients treated worldwide, the IN.PACT Admiral balloon is the best-selling DCB on the market for treatment of femoropopliteal disease.

Proven formulation of paclitaxel in tissue

Only the IN.PACT Admiral DCB releases the drug into the tissue through the restenotic window.

Duration of paclitaxel in tissue†

Bar chart showing the number of days paclitaxel can be measured in tissue for IN.PACT Admiral, Lutonix, Ranger, and Stellarex

Days after index procedure

Clinical evidence

IN.PACT Admiral DCB, with drug in tissue up to 180 days,3 has the:

  • Highest patency benefit through three years compared to PTA‡1
  • Lowest CD-TLR rate through five years1
  • Most publications for a DCB§

View clinical data

How it works

IN.PACT Admiral drug-coated balloon mechanism of action

See how the DCB works.

Ordering information 

Feature

Specifications

Paclitaxel drug dose

3.5 µg/mm2

Excipient

Urea

Balloon diameters

4.0 to 7.0 mm

Balloon lengths

40, 60, 80, 120, 150, 200, and 250 mmll

Balloon fold configurations

4.0 mm: 3 folds; 5.0, 6.0, and 7.0 mm: 6 folds

Catheter design

Over-the-wire (OTW)

Catheter lengths

80 and 130 cm

Guidewire compatibility

0.035 in

Model number
(80 cm catheter)

Model number
(130 cm catheter)

Balloon diameter
(mm)

Balloon length
(mm)

Recommended introducer
sheath (F)

Nominal pressure
(atm)

RBP
(atm)
ADM 040 040 08P ADM 040 040 13P 4.0 40 5 8 14
ADM 040 060 08P ADM 040 060 13P 4.0 60 5 8 14
ADM 040 080 08P ADM 040 080 13P 4.0 80 5 8 14
ADM 040 120 08P ADM 040 120 13P 4.0 120 5 8 14
ADM 040 150 08P ADM 040 150 13P 4.0 150 5 8 14
ADM 040 200 08P ADM 040 200 13P 4.0 200 5 5 11
ADM 040 250 08P ADM 040 250 13P 4.0 250 5 5 11
ADM 050 040 08P ADM 050 040 13P 5.0 40 6 8 14
ADM 050 060 08P ADM 050 060 13P 5.0 60 6 8 14
ADM 050 080 08P ADM 050 080 13P 5.0 80 6 8 14
ADM 050 120 08P ADM 050 120 13P 5.0 120 6 8 14
ADM 050 150 08P ADM 050 150 13P 5.0 150 6 8 14
ADM 050 200 08P ADM 050 200 13P 5.0 200 6 5 11
ADM 050 250 08P ADM 050 250 13P 5.0 250 6 5 11
ADM 060 040 08P ADM 060 040 13P 6.0 40 6 8 14
ADM 060 060 08P ADM 060 060 13P 6.0 60 6 8 14
ADM 060 080 08P ADM 060 080 13P 6.0 80 6 8 14
ADM 060 120 08P ADM 060 120 13P 6.0 120 6 8 14
ADM 060 150 08P ADM 060 150 13P 6.0 150 6 8 14
ADM 060 200 08P ADM 060 200 13P 6.0 200 6 5 11
ADM 060 250 08P ADM 060 250 13P 6.0 250 6 5 11
ADM 070 040 08P ADM 070 040 13P 7.0 40 7 8 14
ADM 070 060 08P ADM 070 060 13P 7.0 60 7 8 14
ADM 070 080 08P ADM 070 080 13P 7.0 80 7 8 14

See the product catalog for complete, detailed product information.

Additional resources

Related pages

Technical manual

Instructions for manual use
Find this technical manual in the Medtronic Manual Library in the product labeling supplied with each device, or by calling Medtronic at 1-763-526-7890.

Connect with us

Reach a Medtronic sales rep
Contact us here

CardioVascular Lifeline Customer Support
1-763-526-7890
rs.cstechsupport@medtronic.com

Orders
1-763-514-8510
rs.cuvasorders@medtronic.com

24-hour Technical Support
1-763-514-4000 (worldwide)

*

™Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

†

Data comes from different individual studies and may differ in a head-to-head comparison, and therefore may not be predictive of clinical results.

‡

Primary patency not assessed after three years.

§

Publications on file with Medtronic.

||

120, 150, 200, and 250 mm lengths are not offered on the 7.0 mm diameter balloon.

References

1

Laird JA, Schneider PA, Jaff MR, et al. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. 5-year results from the IN.PACT SFA Trial. Circ Cardiovasc Interv. June 2019;12(6):e007702.

2

Tepe G. 5-year results from the IN.PACT Global Study Prespecified Cohorts: ISR, CTO and Long Lesions. Presented at VIVA, 2021.

3

FDA. PMA P140010: Summary of safety and effectiveness data. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p140010. Accessed May 23, 2022.

4

FDA. PMA P190019: Summary of safety and effectiveness data. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P190019. Accessed May 23, 2022.

5

Virmani R. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model. Catheter Cardiovasc Interv. January 1, 2014;83(1):132-40.

6

FDA. PMA P160049: Summary of safety and effectiveness data. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160049. Accessed May 23, 2022.